context stringlengths 21 24.6k | category stringclasses 2
values | entity stringlengths 1 12 | entity_type stringclasses 5
values | query stringlengths 97 3.31k | answer stringlengths 12 168 |
|---|---|---|---|---|---|
As of December 31, 2024, the Company has entered into non-cancelable arrangements for subscription software services to make payments aggregating to $ 19.6 million over the next five years . | text | 19.6 | monetaryItemType | text: <entity> 19.6 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company has entered into non-cancelable arrangements for subscription software services to make payments aggregating to $ 19.6 million over the next five years . </context> | us-gaap:ContractualObligation |
The minimum commitments related to the Company's license arrangements aggregate to $ 14.6 million as of December 31, 2024 to be paid over the next 14 years. | text | 14.6 | monetaryItemType | text: <entity> 14.6 </entity> <entity type> monetaryItemType </entity type> <context> The minimum commitments related to the Company's license arrangements aggregate to $ 14.6 million as of December 31, 2024 to be paid over the next 14 years. </context> | us-gaap:ContractualObligation |
For the years ended December 31, 2024, 2023 and 2022, the Company incurred $ 12.6 million, $ 13.6 million and $ 13.1 million, respectively, of operating lease costs and $ 0.5 million, $ 0.2 million and $ 0.4 million, respectively, of variable lease costs. The variable lease cost is comprised primarily of the Company’s ... | text | 12.6 | monetaryItemType | text: <entity> 12.6 </entity> <entity type> monetaryItemType </entity type> <context> For the years ended December 31, 2024, 2023 and 2022, the Company incurred $ 12.6 million, $ 13.6 million and $ 13.1 million, respectively, of operating lease costs and $ 0.5 million, $ 0.2 million and $ 0.4 million, respectively, of ... | us-gaap:OperatingLeaseCost |
For the years ended December 31, 2024, 2023 and 2022, the Company incurred $ 12.6 million, $ 13.6 million and $ 13.1 million, respectively, of operating lease costs and $ 0.5 million, $ 0.2 million and $ 0.4 million, respectively, of variable lease costs. The variable lease cost is comprised primarily of the Company’s ... | text | 13.6 | monetaryItemType | text: <entity> 13.6 </entity> <entity type> monetaryItemType </entity type> <context> For the years ended December 31, 2024, 2023 and 2022, the Company incurred $ 12.6 million, $ 13.6 million and $ 13.1 million, respectively, of operating lease costs and $ 0.5 million, $ 0.2 million and $ 0.4 million, respectively, of ... | us-gaap:OperatingLeaseCost |
For the years ended December 31, 2024, 2023 and 2022, the Company incurred $ 12.6 million, $ 13.6 million and $ 13.1 million, respectively, of operating lease costs and $ 0.5 million, $ 0.2 million and $ 0.4 million, respectively, of variable lease costs. The variable lease cost is comprised primarily of the Company’s ... | text | 13.1 | monetaryItemType | text: <entity> 13.1 </entity> <entity type> monetaryItemType </entity type> <context> For the years ended December 31, 2024, 2023 and 2022, the Company incurred $ 12.6 million, $ 13.6 million and $ 13.1 million, respectively, of operating lease costs and $ 0.5 million, $ 0.2 million and $ 0.4 million, respectively, of ... | us-gaap:OperatingLeaseCost |
For the years ended December 31, 2024, 2023 and 2022, the Company incurred $ 12.6 million, $ 13.6 million and $ 13.1 million, respectively, of operating lease costs and $ 0.5 million, $ 0.2 million and $ 0.4 million, respectively, of variable lease costs. The variable lease cost is comprised primarily of the Company’s ... | text | 0.5 | monetaryItemType | text: <entity> 0.5 </entity> <entity type> monetaryItemType </entity type> <context> For the years ended December 31, 2024, 2023 and 2022, the Company incurred $ 12.6 million, $ 13.6 million and $ 13.1 million, respectively, of operating lease costs and $ 0.5 million, $ 0.2 million and $ 0.4 million, respectively, of v... | us-gaap:VariableLeaseCost |
For the years ended December 31, 2024, 2023 and 2022, the Company incurred $ 12.6 million, $ 13.6 million and $ 13.1 million, respectively, of operating lease costs and $ 0.5 million, $ 0.2 million and $ 0.4 million, respectively, of variable lease costs. The variable lease cost is comprised primarily of the Company’s ... | text | 0.2 | monetaryItemType | text: <entity> 0.2 </entity> <entity type> monetaryItemType </entity type> <context> For the years ended December 31, 2024, 2023 and 2022, the Company incurred $ 12.6 million, $ 13.6 million and $ 13.1 million, respectively, of operating lease costs and $ 0.5 million, $ 0.2 million and $ 0.4 million, respectively, of v... | us-gaap:VariableLeaseCost |
For the years ended December 31, 2024, 2023 and 2022, the Company incurred $ 12.6 million, $ 13.6 million and $ 13.1 million, respectively, of operating lease costs and $ 0.5 million, $ 0.2 million and $ 0.4 million, respectively, of variable lease costs. The variable lease cost is comprised primarily of the Company’s ... | text | 0.4 | monetaryItemType | text: <entity> 0.4 </entity> <entity type> monetaryItemType </entity type> <context> For the years ended December 31, 2024, 2023 and 2022, the Company incurred $ 12.6 million, $ 13.6 million and $ 13.1 million, respectively, of operating lease costs and $ 0.5 million, $ 0.2 million and $ 0.4 million, respectively, of v... | us-gaap:VariableLeaseCost |
For the years ended December 31, 2024, 2023 and 2022, the Company incurred $ 12.6 million, $ 13.6 million and $ 13.1 million, respectively, of operating lease costs and $ 0.5 million, $ 0.2 million and $ 0.4 million, respectively, of variable lease costs. The variable lease cost is comprised primarily of the Company’s ... | text | 1.2 | monetaryItemType | text: <entity> 1.2 </entity> <entity type> monetaryItemType </entity type> <context> For the years ended December 31, 2024, 2023 and 2022, the Company incurred $ 12.6 million, $ 13.6 million and $ 13.1 million, respectively, of operating lease costs and $ 0.5 million, $ 0.2 million and $ 0.4 million, respectively, of v... | us-gaap:SubleaseIncome |
For the years ended December 31, 2024, 2023 and 2022, the Company incurred $ 12.6 million, $ 13.6 million and $ 13.1 million, respectively, of operating lease costs and $ 0.5 million, $ 0.2 million and $ 0.4 million, respectively, of variable lease costs. The variable lease cost is comprised primarily of the Company’s ... | text | 0.5 | monetaryItemType | text: <entity> 0.5 </entity> <entity type> monetaryItemType </entity type> <context> For the years ended December 31, 2024, 2023 and 2022, the Company incurred $ 12.6 million, $ 13.6 million and $ 13.1 million, respectively, of operating lease costs and $ 0.5 million, $ 0.2 million and $ 0.4 million, respectively, of v... | us-gaap:SubleaseIncome |
Cash paid for amounts included in the measurement of operating lease liabilities for the years ended December 31, 2024, 2023 and 2022 were $ 17.8 million, $ 15.2 million and $ 12.1 million, respectively, and were included in net cash used in operating activities in the Company’s consolidated statements of cash flows. | text | 17.8 | monetaryItemType | text: <entity> 17.8 </entity> <entity type> monetaryItemType </entity type> <context> Cash paid for amounts included in the measurement of operating lease liabilities for the years ended December 31, 2024, 2023 and 2022 were $ 17.8 million, $ 15.2 million and $ 12.1 million, respectively, and were included in net cash ... | us-gaap:OperatingLeasePayments |
Cash paid for amounts included in the measurement of operating lease liabilities for the years ended December 31, 2024, 2023 and 2022 were $ 17.8 million, $ 15.2 million and $ 12.1 million, respectively, and were included in net cash used in operating activities in the Company’s consolidated statements of cash flows. | text | 15.2 | monetaryItemType | text: <entity> 15.2 </entity> <entity type> monetaryItemType </entity type> <context> Cash paid for amounts included in the measurement of operating lease liabilities for the years ended December 31, 2024, 2023 and 2022 were $ 17.8 million, $ 15.2 million and $ 12.1 million, respectively, and were included in net cash ... | us-gaap:OperatingLeasePayments |
Cash paid for amounts included in the measurement of operating lease liabilities for the years ended December 31, 2024, 2023 and 2022 were $ 17.8 million, $ 15.2 million and $ 12.1 million, respectively, and were included in net cash used in operating activities in the Company’s consolidated statements of cash flows. | text | 12.1 | monetaryItemType | text: <entity> 12.1 </entity> <entity type> monetaryItemType </entity type> <context> Cash paid for amounts included in the measurement of operating lease liabilities for the years ended December 31, 2024, 2023 and 2022 were $ 17.8 million, $ 15.2 million and $ 12.1 million, respectively, and were included in net cash ... | us-gaap:OperatingLeasePayments |
For the year ended December 31, 2024, the Company incurred approximately $ 1.0 million costs associated with exit activities related to the lease expirations. | text | 1.0 | monetaryItemType | text: <entity> 1.0 </entity> <entity type> monetaryItemType </entity type> <context> For the year ended December 31, 2024, the Company incurred approximately $ 1.0 million costs associated with exit activities related to the lease expirations. </context> | us-gaap:GainLossOnTerminationOfLease |
On May 6, 2021, the Company filed suit against NanoString Technologies, Inc. (“NanoString”) in the U.S. District Court for the District of Delaware alleging that NanoString’s GeoMx Digital Spatial Profiler and associated instruments and reagents infringe U.S. Patent Nos. 10,472,669, 10,662,467, 10,961,566, 10,983,113 a... | text | 31 | monetaryItemType | text: <entity> 31 </entity> <entity type> monetaryItemType </entity type> <context> On May 6, 2021, the Company filed suit against NanoString Technologies, Inc. (“NanoString”) in the U.S. District Court for the District of Delaware alleging that NanoString’s GeoMx Digital Spatial Profiler and associated instruments and... | us-gaap:LossContingencyDamagesSoughtValue |
On May 6, 2021, the Company filed suit against NanoString Technologies, Inc. (“NanoString”) in the U.S. District Court for the District of Delaware alleging that NanoString’s GeoMx Digital Spatial Profiler and associated instruments and reagents infringe U.S. Patent Nos. 10,472,669, 10,662,467, 10,961,566, 10,983,113 a... | text | 25 | monetaryItemType | text: <entity> 25 </entity> <entity type> monetaryItemType </entity type> <context> On May 6, 2021, the Company filed suit against NanoString Technologies, Inc. (“NanoString”) in the U.S. District Court for the District of Delaware alleging that NanoString’s GeoMx Digital Spatial Profiler and associated instruments and... | us-gaap:GainLossRelatedToLitigationSettlement |
On May 6, 2021, the Company filed suit against NanoString Technologies, Inc. (“NanoString”) in the U.S. District Court for the District of Delaware alleging that NanoString’s GeoMx Digital Spatial Profiler and associated instruments and reagents infringe U.S. Patent Nos. 10,472,669, 10,662,467, 10,961,566, 10,983,113 a... | text | 6 | monetaryItemType | text: <entity> 6 </entity> <entity type> monetaryItemType </entity type> <context> On May 6, 2021, the Company filed suit against NanoString Technologies, Inc. (“NanoString”) in the U.S. District Court for the District of Delaware alleging that NanoString’s GeoMx Digital Spatial Profiler and associated instruments and ... | us-gaap:PaymentsForRoyalties |
A hearing date has not yet been set for this appeal. On October 30, 2023, NanoString requested that the Higher Regional Court temporarily stay enforcement of the injunction pending the appeal. On December 20, 2023, the Higher Regional Court granted NanoString’s request conditioned upon NanoString posting a 2.3 million ... | text | 2.3 | monetaryItemType | text: <entity> 2.3 </entity> <entity type> monetaryItemType </entity type> <context> A hearing date has not yet been set for this appeal. On October 30, 2023, NanoString requested that the Higher Regional Court temporarily stay enforcement of the injunction pending the appeal. On December 20, 2023, the Higher Regional ... | us-gaap:SecurityDeposit |
The Company’s Amended and Restated Certificate of Incorporation authorizes it to issue 1,200,000,000 shares of capital stock consisting of 1,000,000,000 shares of Class A common stock, 100,000,000 shares of Class B common stock, and 100,000,000 shares of preferred stock. | text | 100000000 | sharesItemType | text: <entity> 100000000 </entity> <entity type> sharesItemType </entity type> <context> The Company’s Amended and Restated Certificate of Incorporation authorizes it to issue 1,200,000,000 shares of capital stock consisting of 1,000,000,000 shares of Class A common stock, 100,000,000 shares of Class B common stock, an... | us-gaap:PreferredStockSharesAuthorized |
Following the adoption of the 2019 Omnibus Incentive Plan in September 2019, any awards outstanding under the Amended and Restated 2012 Stock Plan continue to be governed by their existing terms but no further awards may be granted under the Amended and Restated 2012 Stock Plan. As of December 31, 2024, the number of s... | text | 1842338 | sharesItemType | text: <entity> 1842338 </entity> <entity type> sharesItemType </entity type> <context> Following the adoption of the 2019 Omnibus Incentive Plan in September 2019, any awards outstanding under the Amended and Restated 2012 Stock Plan continue to be governed by their existing terms but no further awards may be granted u... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant |
The Omnibus Incentive Plan allows for the issuance of incentive stock options (“ISOs”), non-statutory stock options (“NSOs”) or restricted shares. ISOs may be granted only to the Company’s employees (including officers and directors who are also considered employees). NSOs and restricted shares may be granted to the Co... | text | 19637882 | sharesItemType | text: <entity> 19637882 </entity> <entity type> sharesItemType </entity type> <context> The Omnibus Incentive Plan allows for the issuance of incentive stock options (“ISOs”), non-statutory stock options (“NSOs”) or restricted shares. ISOs may be granted only to the Company’s employees (including officers and directors... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant |
The number of shares of Class A common stock reserved for issuance under the 2019 Omnibus Incentive Plan at the time the 2019 Omnibus Incentive Plan was adopted in 2019 was 11,000,000 . The Omnibus Incentive Plan provides that the total number of shares of the Company’s Class A common stock that may be issued under the... | text | 11000000 | sharesItemType | text: <entity> 11000000 </entity> <entity type> sharesItemType </entity type> <context> The number of shares of Class A common stock reserved for issuance under the 2019 Omnibus Incentive Plan at the time the 2019 Omnibus Incentive Plan was adopted in 2019 was 11,000,000 . The Omnibus Incentive Plan provides that the t... | us-gaap:CommonStockCapitalSharesReservedForFutureIssuance |
The number of shares of Class A common stock reserved for issuance under the 2019 Omnibus Incentive Plan at the time the 2019 Omnibus Incentive Plan was adopted in 2019 was 11,000,000 . The Omnibus Incentive Plan provides that the total number of shares of the Company’s Class A common stock that may be issued under the... | text | 11000000 | sharesItemType | text: <entity> 11000000 </entity> <entity type> sharesItemType </entity type> <context> The number of shares of Class A common stock reserved for issuance under the 2019 Omnibus Incentive Plan at the time the 2019 Omnibus Incentive Plan was adopted in 2019 was 11,000,000 . The Omnibus Incentive Plan provides that the t... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized |
The Company did not grant stock options during the year ended December 31, 2024. The weighted-average grant date fair value of options granted during the years ended December 31, 2023 and 2022 was $ 33.67 , and $ 32.95 per share, respectively. The total intrinsic value of stock options exercised was $ 12.3 million, $ 7... | text | 33.67 | perShareItemType | text: <entity> 33.67 </entity> <entity type> perShareItemType </entity type> <context> The Company did not grant stock options during the year ended December 31, 2024. The weighted-average grant date fair value of options granted during the years ended December 31, 2023 and 2022 was $ 33.67 , and $ 32.95 per share, res... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
The Company did not grant stock options during the year ended December 31, 2024. The weighted-average grant date fair value of options granted during the years ended December 31, 2023 and 2022 was $ 33.67 , and $ 32.95 per share, respectively. The total intrinsic value of stock options exercised was $ 12.3 million, $ 7... | text | 32.95 | perShareItemType | text: <entity> 32.95 </entity> <entity type> perShareItemType </entity type> <context> The Company did not grant stock options during the year ended December 31, 2024. The weighted-average grant date fair value of options granted during the years ended December 31, 2023 and 2022 was $ 33.67 , and $ 32.95 per share, res... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
The Company did not grant stock options during the year ended December 31, 2024. The weighted-average grant date fair value of options granted during the years ended December 31, 2023 and 2022 was $ 33.67 , and $ 32.95 per share, respectively. The total intrinsic value of stock options exercised was $ 12.3 million, $ 7... | text | 12.3 | monetaryItemType | text: <entity> 12.3 </entity> <entity type> monetaryItemType </entity type> <context> The Company did not grant stock options during the year ended December 31, 2024. The weighted-average grant date fair value of options granted during the years ended December 31, 2023 and 2022 was $ 33.67 , and $ 32.95 per share, resp... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue |
The Company did not grant stock options during the year ended December 31, 2024. The weighted-average grant date fair value of options granted during the years ended December 31, 2023 and 2022 was $ 33.67 , and $ 32.95 per share, respectively. The total intrinsic value of stock options exercised was $ 12.3 million, $ 7... | text | 78.0 | monetaryItemType | text: <entity> 78.0 </entity> <entity type> monetaryItemType </entity type> <context> The Company did not grant stock options during the year ended December 31, 2024. The weighted-average grant date fair value of options granted during the years ended December 31, 2023 and 2022 was $ 33.67 , and $ 32.95 per share, resp... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue |
The Company did not grant stock options during the year ended December 31, 2024. The weighted-average grant date fair value of options granted during the years ended December 31, 2023 and 2022 was $ 33.67 , and $ 32.95 per share, respectively. The total intrinsic value of stock options exercised was $ 12.3 million, $ 7... | text | 89.5 | monetaryItemType | text: <entity> 89.5 </entity> <entity type> monetaryItemType </entity type> <context> The Company did not grant stock options during the year ended December 31, 2024. The weighted-average grant date fair value of options granted during the years ended December 31, 2023 and 2022 was $ 33.67 , and $ 32.95 per share, resp... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue |
The Company did not grant stock options during the year ended December 31, 2024. The weighted-average grant date fair value of options granted during the years ended December 31, 2023 and 2022 was $ 33.67 , and $ 32.95 per share, respectively. The total intrinsic value of stock options exercised was $ 12.3 million, $ 7... | text | 19.5 | monetaryItemType | text: <entity> 19.5 </entity> <entity type> monetaryItemType </entity type> <context> The Company did not grant stock options during the year ended December 31, 2024. The weighted-average grant date fair value of options granted during the years ended December 31, 2023 and 2022 was $ 33.67 , and $ 32.95 per share, resp... | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized |
As of December 31, 2024, the total unrecognized stock-based compensation related to RSUs was $ 194.4 million, which will be recognized over a weighted-average period of approximately three years . | text | 194.4 | monetaryItemType | text: <entity> 194.4 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the total unrecognized stock-based compensation related to RSUs was $ 194.4 million, which will be recognized over a weighted-average period of approximately three years . </context> | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized |
In March 2024, the Company granted 219,168 performance stock units (“PSUs”) under the 2019 Plan to certain members of management which are subject to the achievement of certain performance conditions established by the Company’s Compensation Committee of the Board of Directors as described below: | text | 219168 | sharesItemType | text: <entity> 219168 </entity> <entity type> sharesItemType </entity type> <context> In March 2024, the Company granted 219,168 performance stock units (“PSUs”) under the 2019 Plan to certain members of management which are subject to the achievement of certain performance conditions established by the Company’s Compe... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
50 % of target PSUs earned will be based on the Company’s compound annual growth rate (CAGR) of the Company’s Revenue over a two-year performance period from January 1, 2024 to December 31, 2025. Holders may earn from 0 % to 175 % of the target amount of shares and earned PSUs will then be subject to service-based vest... | text | 50 | percentItemType | text: <entity> 50 </entity> <entity type> percentItemType </entity type> <context> 50 % of target PSUs earned will be based on the Company’s compound annual growth rate (CAGR) of the Company’s Revenue over a two-year performance period from January 1, 2024 to December 31, 2025. Holders may earn from 0 % to 175 % of the... | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage |
50 % of target PSUs earned will be based on the relative Total Shareholder Return (TSR) of the Company’s common stock as compared to the TSR of the members of the Russell 3000 Medical Equipment and Services Sector Index over a three-year performance period from January 1, 2024 to December 31, 2026. Depending on the res... | text | 50 | percentItemType | text: <entity> 50 </entity> <entity type> percentItemType </entity type> <context> 50 % of target PSUs earned will be based on the relative Total Shareholder Return (TSR) of the Company’s common stock as compared to the TSR of the members of the Russell 3000 Medical Equipment and Services Sector Index over a three-year... | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage |
The weighted-average grant date fair values of the PSUs relating to CAGR and TSR components were $ 37.43 and $ 44.80 per share respectively. Stock-based compensation expense recognized for the PSUs relating to TSR components were approximately $ 1.3 million for the year ended December 31, 2024. The PSUs relating to CAG... | text | 37.43 | perShareItemType | text: <entity> 37.43 </entity> <entity type> perShareItemType </entity type> <context> The weighted-average grant date fair values of the PSUs relating to CAGR and TSR components were $ 37.43 and $ 44.80 per share respectively. Stock-based compensation expense recognized for the PSUs relating to TSR components were app... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
The weighted-average grant date fair values of the PSUs relating to CAGR and TSR components were $ 37.43 and $ 44.80 per share respectively. Stock-based compensation expense recognized for the PSUs relating to TSR components were approximately $ 1.3 million for the year ended December 31, 2024. The PSUs relating to CAG... | text | 44.80 | perShareItemType | text: <entity> 44.80 </entity> <entity type> perShareItemType </entity type> <context> The weighted-average grant date fair values of the PSUs relating to CAGR and TSR components were $ 37.43 and $ 44.80 per share respectively. Stock-based compensation expense recognized for the PSUs relating to TSR components were app... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
The weighted-average grant date fair values of the PSUs relating to CAGR and TSR components were $ 37.43 and $ 44.80 per share respectively. Stock-based compensation expense recognized for the PSUs relating to TSR components were approximately $ 1.3 million for the year ended December 31, 2024. The PSUs relating to CAG... | text | 1.3 | monetaryItemType | text: <entity> 1.3 </entity> <entity type> monetaryItemType </entity type> <context> The weighted-average grant date fair values of the PSUs relating to CAGR and TSR components were $ 37.43 and $ 44.80 per share respectively. Stock-based compensation expense recognized for the PSUs relating to TSR components were appro... | us-gaap:EmployeeBenefitsAndShareBasedCompensation |
In March 2023, the Company granted 172,842 performance restricted stock unit awards (“PSAs”) under the 2019 Plan to certain members of management, which are subject to the achievement of certain escalating stock price thresholds established by the Company's Compensation Committee of the Board of Directors. | text | 172842 | sharesItemType | text: <entity> 172842 </entity> <entity type> sharesItemType </entity type> <context> In March 2023, the Company granted 172,842 performance restricted stock unit awards (“PSAs”) under the 2019 Plan to certain members of management, which are subject to the achievement of certain escalating stock price thresholds estab... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
The PSAs each vest in equal installments upon the achievement of escalating stock price thresholds of $ 72.14 , $ 96.19 and $ 120.24 respectively, calculated based on the volume-weighted average price per share of the Company’s Class A common stock over the immediately trailing 20 trading day period for each respective... | text | 43.13 | perShareItemType | text: <entity> 43.13 </entity> <entity type> perShareItemType </entity type> <context> The PSAs each vest in equal installments upon the achievement of escalating stock price thresholds of $ 72.14 , $ 96.19 and $ 120.24 respectively, calculated based on the volume-weighted average price per share of the Company’s Class... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
The PSAs each vest in equal installments upon the achievement of escalating stock price thresholds of $ 72.14 , $ 96.19 and $ 120.24 respectively, calculated based on the volume-weighted average price per share of the Company’s Class A common stock over the immediately trailing 20 trading day period for each respective... | text | 1.7 | monetaryItemType | text: <entity> 1.7 </entity> <entity type> monetaryItemType </entity type> <context> The PSAs each vest in equal installments upon the achievement of escalating stock price thresholds of $ 72.14 , $ 96.19 and $ 120.24 respectively, calculated based on the volume-weighted average price per share of the Company’s Class A... | us-gaap:EmployeeBenefitsAndShareBasedCompensation |
The PSAs each vest in equal installments upon the achievement of escalating stock price thresholds of $ 72.14 , $ 96.19 and $ 120.24 respectively, calculated based on the volume-weighted average price per share of the Company’s Class A common stock over the immediately trailing 20 trading day period for each respective... | text | 5.1 | monetaryItemType | text: <entity> 5.1 </entity> <entity type> monetaryItemType </entity type> <context> The PSAs each vest in equal installments upon the achievement of escalating stock price thresholds of $ 72.14 , $ 96.19 and $ 120.24 respectively, calculated based on the volume-weighted average price per share of the Company’s Class A... | us-gaap:EmployeeBenefitsAndShareBasedCompensation |
In September 2022, the Company granted 709,025 PSAs including RSUs and a performance stock option under the 2019 Plan to certain members of management, which are subject to the achievement of certain stock price thresholds established by the Company’s Compensation Committee of the Board of Directors. | text | 709025 | sharesItemType | text: <entity> 709025 </entity> <entity type> sharesItemType </entity type> <context> In September 2022, the Company granted 709,025 PSAs including RSUs and a performance stock option under the 2019 Plan to certain members of management, which are subject to the achievement of certain stock price thresholds established... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
The PSAs consist of three separate tranches and the vesting of each tranche is subject to the Class A common stock closing price being maintained at or above the predetermined share price goals of $ 60 , $ 80 and $ 105 for each tranche, respectively, for a period of 20 consecutive trading days. The share price goals ca... | text | 22.55 | perShareItemType | text: <entity> 22.55 </entity> <entity type> perShareItemType </entity type> <context> The PSAs consist of three separate tranches and the vesting of each tranche is subject to the Class A common stock closing price being maintained at or above the predetermined share price goals of $ 60 , $ 80 and $ 105 for each tranc... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
The PSAs consist of three separate tranches and the vesting of each tranche is subject to the Class A common stock closing price being maintained at or above the predetermined share price goals of $ 60 , $ 80 and $ 105 for each tranche, respectively, for a period of 20 consecutive trading days. The share price goals ca... | text | 2.4 | monetaryItemType | text: <entity> 2.4 </entity> <entity type> monetaryItemType </entity type> <context> The PSAs consist of three separate tranches and the vesting of each tranche is subject to the Class A common stock closing price being maintained at or above the predetermined share price goals of $ 60 , $ 80 and $ 105 for each tranche... | us-gaap:EmployeeBenefitsAndShareBasedCompensation |
The PSAs consist of three separate tranches and the vesting of each tranche is subject to the Class A common stock closing price being maintained at or above the predetermined share price goals of $ 60 , $ 80 and $ 105 for each tranche, respectively, for a period of 20 consecutive trading days. The share price goals ca... | text | 10.0 | monetaryItemType | text: <entity> 10.0 </entity> <entity type> monetaryItemType </entity type> <context> The PSAs consist of three separate tranches and the vesting of each tranche is subject to the Class A common stock closing price being maintained at or above the predetermined share price goals of $ 60 , $ 80 and $ 105 for each tranch... | us-gaap:EmployeeBenefitsAndShareBasedCompensation |
The PSAs consist of three separate tranches and the vesting of each tranche is subject to the Class A common stock closing price being maintained at or above the predetermined share price goals of $ 60 , $ 80 and $ 105 for each tranche, respectively, for a period of 20 consecutive trading days. The share price goals ca... | text | 3.3 | monetaryItemType | text: <entity> 3.3 </entity> <entity type> monetaryItemType </entity type> <context> The PSAs consist of three separate tranches and the vesting of each tranche is subject to the Class A common stock closing price being maintained at or above the predetermined share price goals of $ 60 , $ 80 and $ 105 for each tranche... | us-gaap:EmployeeBenefitsAndShareBasedCompensation |
In July 2019, the Company’s board of directors adopted the 10x Genomics, Inc. 2019 Employee Stock Purchase Plan (the “ESPP”), which was subsequently approved by the Company’s stockholders. The ESPP went into effect on September 11, 2019. Subject to any limitations contained therein, the ESPP allows eligible employees t... | text | 15 | percentItemType | text: <entity> 15 </entity> <entity type> percentItemType </entity type> <context> In July 2019, the Company’s board of directors adopted the 10x Genomics, Inc. 2019 Employee Stock Purchase Plan (the “ESPP”), which was subsequently approved by the Company’s stockholders. The ESPP went into effect on September 11, 2019.... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate |
During the years ended December 31, 2024, 2023 and 2022, 385,967 , 217,537 , and 151,028 shares of Class A common stock, respectively, were issued under the ESPP. The ESPP provides that the maximum number of shares of the Company’s Class A common stock made available for sale thereunder will be 3,686,671 , which number... | text | 385967 | sharesItemType | text: <entity> 385967 </entity> <entity type> sharesItemType </entity type> <context> During the years ended December 31, 2024, 2023 and 2022, 385,967 , 217,537 , and 151,028 shares of Class A common stock, respectively, were issued under the ESPP. The ESPP provides that the maximum number of shares of the Company’s Cl... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod |
During the years ended December 31, 2024, 2023 and 2022, 385,967 , 217,537 , and 151,028 shares of Class A common stock, respectively, were issued under the ESPP. The ESPP provides that the maximum number of shares of the Company’s Class A common stock made available for sale thereunder will be 3,686,671 , which number... | text | 217537 | sharesItemType | text: <entity> 217537 </entity> <entity type> sharesItemType </entity type> <context> During the years ended December 31, 2024, 2023 and 2022, 385,967 , 217,537 , and 151,028 shares of Class A common stock, respectively, were issued under the ESPP. The ESPP provides that the maximum number of shares of the Company’s Cl... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod |
During the years ended December 31, 2024, 2023 and 2022, 385,967 , 217,537 , and 151,028 shares of Class A common stock, respectively, were issued under the ESPP. The ESPP provides that the maximum number of shares of the Company’s Class A common stock made available for sale thereunder will be 3,686,671 , which number... | text | 151028 | sharesItemType | text: <entity> 151028 </entity> <entity type> sharesItemType </entity type> <context> During the years ended December 31, 2024, 2023 and 2022, 385,967 , 217,537 , and 151,028 shares of Class A common stock, respectively, were issued under the ESPP. The ESPP provides that the maximum number of shares of the Company’s Cl... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod |
During the years ended December 31, 2024, 2023 and 2022, 385,967 , 217,537 , and 151,028 shares of Class A common stock, respectively, were issued under the ESPP. The ESPP provides that the maximum number of shares of the Company’s Class A common stock made available for sale thereunder will be 3,686,671 , which number... | text | 3686671 | sharesItemType | text: <entity> 3686671 </entity> <entity type> sharesItemType </entity type> <context> During the years ended December 31, 2024, 2023 and 2022, 385,967 , 217,537 , and 151,028 shares of Class A common stock, respectively, were issued under the ESPP. The ESPP provides that the maximum number of shares of the Company’s C... | us-gaap:CommonStockCapitalSharesReservedForFutureIssuance |
During the years ended December 31, 2024, 2023 and 2022, 385,967 , 217,537 , and 151,028 shares of Class A common stock, respectively, were issued under the ESPP. The ESPP provides that the maximum number of shares of the Company’s Class A common stock made available for sale thereunder will be 3,686,671 , which number... | text | 2705096 | sharesItemType | text: <entity> 2705096 </entity> <entity type> sharesItemType </entity type> <context> During the years ended December 31, 2024, 2023 and 2022, 385,967 , 217,537 , and 151,028 shares of Class A common stock, respectively, were issued under the ESPP. The ESPP provides that the maximum number of shares of the Company’s C... | us-gaap:CommonStockCapitalSharesReservedForFutureIssuance |
For the years ended December 31, 2024, 2023, and 2022 the weighted average grant date fair values of options granted under the ESPP, using the Black-Scholes option pricing model, were $ 6.42 , $ 16.91 , and $ 33.74 respectively. | text | 6.42 | perShareItemType | text: <entity> 6.42 </entity> <entity type> perShareItemType </entity type> <context> For the years ended December 31, 2024, 2023, and 2022 the weighted average grant date fair values of options granted under the ESPP, using the Black-Scholes option pricing model, were $ 6.42 , $ 16.91 , and $ 33.74 respectively. </con... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
For the years ended December 31, 2024, 2023, and 2022 the weighted average grant date fair values of options granted under the ESPP, using the Black-Scholes option pricing model, were $ 6.42 , $ 16.91 , and $ 33.74 respectively. | text | 16.91 | perShareItemType | text: <entity> 16.91 </entity> <entity type> perShareItemType </entity type> <context> For the years ended December 31, 2024, 2023, and 2022 the weighted average grant date fair values of options granted under the ESPP, using the Black-Scholes option pricing model, were $ 6.42 , $ 16.91 , and $ 33.74 respectively. </co... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
For the years ended December 31, 2024, 2023, and 2022 the weighted average grant date fair values of options granted under the ESPP, using the Black-Scholes option pricing model, were $ 6.42 , $ 16.91 , and $ 33.74 respectively. | text | 33.74 | perShareItemType | text: <entity> 33.74 </entity> <entity type> perShareItemType </entity type> <context> For the years ended December 31, 2024, 2023, and 2022 the weighted average grant date fair values of options granted under the ESPP, using the Black-Scholes option pricing model, were $ 6.42 , $ 16.91 , and $ 33.74 respectively. </co... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
As of December 31, 2024, the total unrecognized stock-based compensation related to the ESPP was $ 1.5 million, which will be recognized over a weighted-average period of approximately 0.4 years. | text | 1.5 | monetaryItemType | text: <entity> 1.5 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the total unrecognized stock-based compensation related to the ESPP was $ 1.5 million, which will be recognized over a weighted-average period of approximately 0.4 years. </context> | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized |
The Company has made available to all full-time United States employees a 401(k) retirement savings plan. Under this plan, employee and employer contributions and accumulated plan earnings qualify for favorable tax treatment under Section 401(k) of the Internal Revenue Code. The Company matches 100 % of the first 3 % o... | text | 100 | percentItemType | text: <entity> 100 </entity> <entity type> percentItemType </entity type> <context> The Company has made available to all full-time United States employees a 401(k) retirement savings plan. Under this plan, employee and employer contributions and accumulated plan earnings qualify for favorable tax treatment under Secti... | us-gaap:DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage |
The Company has made available to all full-time United States employees a 401(k) retirement savings plan. Under this plan, employee and employer contributions and accumulated plan earnings qualify for favorable tax treatment under Section 401(k) of the Internal Revenue Code. The Company matches 100 % of the first 3 % o... | text | 3 | percentItemType | text: <entity> 3 </entity> <entity type> percentItemType </entity type> <context> The Company has made available to all full-time United States employees a 401(k) retirement savings plan. Under this plan, employee and employer contributions and accumulated plan earnings qualify for favorable tax treatment under Section... | us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch |
The Company has made available to all full-time United States employees a 401(k) retirement savings plan. Under this plan, employee and employer contributions and accumulated plan earnings qualify for favorable tax treatment under Section 401(k) of the Internal Revenue Code. The Company matches 100 % of the first 3 % o... | text | two thousand | monetaryItemType | text: <entity> two thousand </entity> <entity type> monetaryItemType </entity type> <context> The Company has made available to all full-time United States employees a 401(k) retirement savings plan. Under this plan, employee and employer contributions and accumulated plan earnings qualify for favorable tax treatment u... | us-gaap:DefinedBenefitPlanContributionsByEmployer |
The Company has made available to all full-time United States employees a 401(k) retirement savings plan. Under this plan, employee and employer contributions and accumulated plan earnings qualify for favorable tax treatment under Section 401(k) of the Internal Revenue Code. The Company matches 100 % of the first 3 % o... | text | 1.9 | monetaryItemType | text: <entity> 1.9 </entity> <entity type> monetaryItemType </entity type> <context> The Company has made available to all full-time United States employees a 401(k) retirement savings plan. Under this plan, employee and employer contributions and accumulated plan earnings qualify for favorable tax treatment under Sect... | us-gaap:DefinedBenefitPlanContributionsByEmployer |
The Company has made available to all full-time United States employees a 401(k) retirement savings plan. Under this plan, employee and employer contributions and accumulated plan earnings qualify for favorable tax treatment under Section 401(k) of the Internal Revenue Code. The Company matches 100 % of the first 3 % o... | text | 1.8 | monetaryItemType | text: <entity> 1.8 </entity> <entity type> monetaryItemType </entity type> <context> The Company has made available to all full-time United States employees a 401(k) retirement savings plan. Under this plan, employee and employer contributions and accumulated plan earnings qualify for favorable tax treatment under Sect... | us-gaap:DefinedBenefitPlanContributionsByEmployer |
The Company has made available to all full-time United States employees a 401(k) retirement savings plan. Under this plan, employee and employer contributions and accumulated plan earnings qualify for favorable tax treatment under Section 401(k) of the Internal Revenue Code. The Company matches 100 % of the first 3 % o... | text | 2.0 | monetaryItemType | text: <entity> 2.0 </entity> <entity type> monetaryItemType </entity type> <context> The Company has made available to all full-time United States employees a 401(k) retirement savings plan. Under this plan, employee and employer contributions and accumulated plan earnings qualify for favorable tax treatment under Sect... | us-gaap:DefinedBenefitPlanContributionsByEmployer |
Omega has elected to be taxed as a real estate investment trust (“REIT”) for federal income tax purposes and is structured as an umbrella partnership REIT (“UPREIT”) under which all of Omega's assets are owned directly or indirectly by, and all of Omega's operations are conducted directly or indirectly through, its ope... | text | 97 | percentItemType | text: <entity> 97 </entity> <entity type> percentItemType </entity type> <context> Omega has elected to be taxed as a real estate investment trust (“REIT”) for federal income tax purposes and is structured as an umbrella partnership REIT (“UPREIT”) under which all of Omega's assets are owned directly or indirectly by, ... | us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest |
Omega has elected to be taxed as a real estate investment trust (“REIT”) for federal income tax purposes and is structured as an umbrella partnership REIT (“UPREIT”) under which all of Omega's assets are owned directly or indirectly by, and all of Omega's operations are conducted directly or indirectly through, its ope... | text | 3 | percentItemType | text: <entity> 3 </entity> <entity type> percentItemType </entity type> <context> Omega has elected to be taxed as a real estate investment trust (“REIT”) for federal income tax purposes and is structured as an umbrella partnership REIT (“UPREIT”) under which all of Omega's assets are owned directly or indirectly by, a... | us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest |
Real estate properties are carried at initial recorded value less accumulated depreciation. The costs of significant improvements, renovations and replacements, including interest are capitalized. Our interest expense reflected in the Consolidated Statements of Operations has been reduced by the amounts capitalized. Fo... | text | 7.3 | monetaryItemType | text: <entity> 7.3 </entity> <entity type> monetaryItemType </entity type> <context> Real estate properties are carried at initial recorded value less accumulated depreciation. The costs of significant improvements, renovations and replacements, including interest are capitalized. Our interest expense reflected in the ... | us-gaap:RealEstateInventoryCapitalizedInterestCosts |
Real estate properties are carried at initial recorded value less accumulated depreciation. The costs of significant improvements, renovations and replacements, including interest are capitalized. Our interest expense reflected in the Consolidated Statements of Operations has been reduced by the amounts capitalized. Fo... | text | 4.3 | monetaryItemType | text: <entity> 4.3 </entity> <entity type> monetaryItemType </entity type> <context> Real estate properties are carried at initial recorded value less accumulated depreciation. The costs of significant improvements, renovations and replacements, including interest are capitalized. Our interest expense reflected in the ... | us-gaap:RealEstateInventoryCapitalizedInterestCosts |
Real estate properties are carried at initial recorded value less accumulated depreciation. The costs of significant improvements, renovations and replacements, including interest are capitalized. Our interest expense reflected in the Consolidated Statements of Operations has been reduced by the amounts capitalized. Fo... | text | 3.2 | monetaryItemType | text: <entity> 3.2 </entity> <entity type> monetaryItemType </entity type> <context> Real estate properties are carried at initial recorded value less accumulated depreciation. The costs of significant improvements, renovations and replacements, including interest are capitalized. Our interest expense reflected in the ... | us-gaap:RealEstateInventoryCapitalizedInterestCosts |
We obtain liquidity deposits and other deposits, security deposits and letters of credit from certain operators pursuant to our lease and mortgage agreements. These generally represent the rental and/or mortgage interest for periods ranging from three to six months with respect to certain of our investments or the requ... | text | 15.5 | monetaryItemType | text: <entity> 15.5 </entity> <entity type> monetaryItemType </entity type> <context> We obtain liquidity deposits and other deposits, security deposits and letters of credit from certain operators pursuant to our lease and mortgage agreements. These generally represent the rental and/or mortgage interest for periods r... | us-gaap:SecurityDeposit |
We obtain liquidity deposits and other deposits, security deposits and letters of credit from certain operators pursuant to our lease and mortgage agreements. These generally represent the rental and/or mortgage interest for periods ranging from three to six months with respect to certain of our investments or the requ... | text | 1.9 | monetaryItemType | text: <entity> 1.9 </entity> <entity type> monetaryItemType </entity type> <context> We obtain liquidity deposits and other deposits, security deposits and letters of credit from certain operators pursuant to our lease and mortgage agreements. These generally represent the rental and/or mortgage interest for periods ra... | us-gaap:SecurityDeposit |
We obtain liquidity deposits and other deposits, security deposits and letters of credit from certain operators pursuant to our lease and mortgage agreements. These generally represent the rental and/or mortgage interest for periods ranging from three to six months with respect to certain of our investments or the requ... | text | 52.7 | monetaryItemType | text: <entity> 52.7 </entity> <entity type> monetaryItemType </entity type> <context> We obtain liquidity deposits and other deposits, security deposits and letters of credit from certain operators pursuant to our lease and mortgage agreements. These generally represent the rental and/or mortgage interest for periods r... | us-gaap:SecurityDeposit |
We obtain liquidity deposits and other deposits, security deposits and letters of credit from certain operators pursuant to our lease and mortgage agreements. These generally represent the rental and/or mortgage interest for periods ranging from three to six months with respect to certain of our investments or the requ... | text | 36.0 | monetaryItemType | text: <entity> 36.0 </entity> <entity type> monetaryItemType </entity type> <context> We obtain liquidity deposits and other deposits, security deposits and letters of credit from certain operators pursuant to our lease and mortgage agreements. These generally represent the rental and/or mortgage interest for periods r... | us-gaap:SecurityDeposit |
We obtain liquidity deposits and other deposits, security deposits and letters of credit from certain operators pursuant to our lease and mortgage agreements. These generally represent the rental and/or mortgage interest for periods ranging from three to six months with respect to certain of our investments or the requ... | text | 29.1 | monetaryItemType | text: <entity> 29.1 </entity> <entity type> monetaryItemType </entity type> <context> We obtain liquidity deposits and other deposits, security deposits and letters of credit from certain operators pursuant to our lease and mortgage agreements. These generally represent the rental and/or mortgage interest for periods r... | us-gaap:SecurityDeposit |
We obtain liquidity deposits and other deposits, security deposits and letters of credit from certain operators pursuant to our lease and mortgage agreements. These generally represent the rental and/or mortgage interest for periods ranging from three to six months with respect to certain of our investments or the requ... | text | 27.1 | monetaryItemType | text: <entity> 27.1 </entity> <entity type> monetaryItemType </entity type> <context> We obtain liquidity deposits and other deposits, security deposits and letters of credit from certain operators pursuant to our lease and mortgage agreements. These generally represent the rental and/or mortgage interest for periods r... | us-gaap:SecurityDeposit |
External costs incurred from the placement of our debt are capitalized and amortized on a straight-line basis over the terms of the related borrowings which approximates the effective interest method. Deferred financing costs related to our revolving line of credit are included in other assets on our Consolidated Balan... | text | 10.4 | monetaryItemType | text: <entity> 10.4 </entity> <entity type> monetaryItemType </entity type> <context> External costs incurred from the placement of our debt are capitalized and amortized on a straight-line basis over the terms of the related borrowings which approximates the effective interest method. Deferred financing costs related ... | us-gaap:AmortizationOfFinancingCosts |
External costs incurred from the placement of our debt are capitalized and amortized on a straight-line basis over the terms of the related borrowings which approximates the effective interest method. Deferred financing costs related to our revolving line of credit are included in other assets on our Consolidated Balan... | text | 13.7 | monetaryItemType | text: <entity> 13.7 </entity> <entity type> monetaryItemType </entity type> <context> External costs incurred from the placement of our debt are capitalized and amortized on a straight-line basis over the terms of the related borrowings which approximates the effective interest method. Deferred financing costs related ... | us-gaap:AmortizationOfFinancingCosts |
External costs incurred from the placement of our debt are capitalized and amortized on a straight-line basis over the terms of the related borrowings which approximates the effective interest method. Deferred financing costs related to our revolving line of credit are included in other assets on our Consolidated Balan... | text | 12.9 | monetaryItemType | text: <entity> 12.9 </entity> <entity type> monetaryItemType </entity type> <context> External costs incurred from the placement of our debt are capitalized and amortized on a straight-line basis over the terms of the related borrowings which approximates the effective interest method. Deferred financing costs related ... | us-gaap:AmortizationOfFinancingCosts |
The noncontrolling interest for Omega primarily represents the outstanding Omega OP Units held by outside investors. Each of the Omega OP Units (other than the Omega OP Units owned by Omega) is redeemable at the election of the Omega OP Unit holder for cash equal to the then-fair market value of one share of Omega comm... | text | 0.10 | perShareItemType | text: <entity> 0.10 </entity> <entity type> perShareItemType </entity type> <context> The noncontrolling interest for Omega primarily represents the outstanding Omega OP Units held by outside investors. Each of the Omega OP Units (other than the Omega OP Units owned by Omega) is redeemable at the election of the Omega ... | us-gaap:CommonStockParOrStatedValuePerShare |
The noncontrolling interest for Omega primarily represents the outstanding Omega OP Units held by outside investors. Each of the Omega OP Units (other than the Omega OP Units owned by Omega) is redeemable at the election of the Omega OP Unit holder for cash equal to the then-fair market value of one share of Omega comm... | text | 97 | percentItemType | text: <entity> 97 </entity> <entity type> percentItemType </entity type> <context> The noncontrolling interest for Omega primarily represents the outstanding Omega OP Units held by outside investors. Each of the Omega OP Units (other than the Omega OP Units owned by Omega) is redeemable at the election of the Omega OP ... | us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest |
The noncontrolling interest for Omega primarily represents the outstanding Omega OP Units held by outside investors. Each of the Omega OP Units (other than the Omega OP Units owned by Omega) is redeemable at the election of the Omega OP Unit holder for cash equal to the then-fair market value of one share of Omega comm... | text | 3 | percentItemType | text: <entity> 3 </entity> <entity type> percentItemType </entity type> <context> The noncontrolling interest for Omega primarily represents the outstanding Omega OP Units held by outside investors. Each of the Omega OP Units (other than the Omega OP Units owned by Omega) is redeemable at the election of the Omega OP U... | us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest |
The U.S. dollar (“USD”) is the functional currency for our consolidated subsidiaries operating in the U.S. The functional currency for our consolidated subsidiaries operating in the U.K. is the British Pound (“GBP”). Total revenues from our consolidated U.K. operating subsidiaries were $ 93.6 million, $ 56.8 million an... | text | 93.6 | monetaryItemType | text: <entity> 93.6 </entity> <entity type> monetaryItemType </entity type> <context> The U.S. dollar (“USD”) is the functional currency for our consolidated subsidiaries operating in the U.S. The functional currency for our consolidated subsidiaries operating in the U.K. is the British Pound (“GBP”). Total revenues fr... | us-gaap:Revenues |
The U.S. dollar (“USD”) is the functional currency for our consolidated subsidiaries operating in the U.S. The functional currency for our consolidated subsidiaries operating in the U.K. is the British Pound (“GBP”). Total revenues from our consolidated U.K. operating subsidiaries were $ 93.6 million, $ 56.8 million an... | text | 56.8 | monetaryItemType | text: <entity> 56.8 </entity> <entity type> monetaryItemType </entity type> <context> The U.S. dollar (“USD”) is the functional currency for our consolidated subsidiaries operating in the U.S. The functional currency for our consolidated subsidiaries operating in the U.K. is the British Pound (“GBP”). Total revenues fr... | us-gaap:Revenues |
The U.S. dollar (“USD”) is the functional currency for our consolidated subsidiaries operating in the U.S. The functional currency for our consolidated subsidiaries operating in the U.K. is the British Pound (“GBP”). Total revenues from our consolidated U.K. operating subsidiaries were $ 93.6 million, $ 56.8 million an... | text | 47.7 | monetaryItemType | text: <entity> 47.7 </entity> <entity type> monetaryItemType </entity type> <context> The U.S. dollar (“USD”) is the functional currency for our consolidated subsidiaries operating in the U.S. The functional currency for our consolidated subsidiaries operating in the U.K. is the British Pound (“GBP”). Total revenues fr... | us-gaap:Revenues |
Certain amounts in the prior year period have been reclassified to conform to the current period presentation. Income from direct financing leases, which was previously reported separately on our Consolidated Statements of Operations, is now included in rental income for all periods presented. In addition, we previousl... | text | 93.7 | monetaryItemType | text: <entity> 93.7 </entity> <entity type> monetaryItemType </entity type> <context> Certain amounts in the prior year period have been reclassified to conform to the current period presentation. Income from direct financing leases, which was previously reported separately on our Consolidated Statements of Operations,... | us-gaap:RealEstateHeldforsale |
On March 12, 2020, the FASB issued ASU 2020-04, which contains optional practical expedients for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting for contracts, hedging relationships, and other transactions that referenc... | text | 1.45 | monetaryItemType | text: <entity> 1.45 </entity> <entity type> monetaryItemType </entity type> <context> On March 12, 2020, the FASB issued ASU 2020-04, which contains optional practical expedients for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financia... | us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity |
On March 12, 2020, the FASB issued ASU 2020-04, which contains optional practical expedients for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting for contracts, hedging relationships, and other transactions that referenc... | text | 50.0 | monetaryItemType | text: <entity> 50.0 </entity> <entity type> monetaryItemType </entity type> <context> On March 12, 2020, the FASB issued ASU 2020-04, which contains optional practical expedients for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financia... | us-gaap:OtherLoansPayable |
As of December 31, 2023, we held a 49 % interest in an unconsolidated real estate joint venture owning 63 facilities in the U.K. (the “Cindat Joint Venture”) accounted for using the equity method of accounting. As of December 31, 2023, our equity interest was $ 97.6 million. The 63 facilities are subject to leases with... | text | 49 | percentItemType | text: <entity> 49 </entity> <entity type> percentItemType </entity type> <context> As of December 31, 2023, we held a 49 % interest in an unconsolidated real estate joint venture owning 63 facilities in the U.K. (the “Cindat Joint Venture”) accounted for using the equity method of accounting. As of December 31, 2023, o... | us-gaap:EquityMethodInvestmentOwnershipPercentage |
As of December 31, 2023, we held a 49 % interest in an unconsolidated real estate joint venture owning 63 facilities in the U.K. (the “Cindat Joint Venture”) accounted for using the equity method of accounting. As of December 31, 2023, our equity interest was $ 97.6 million. The 63 facilities are subject to leases with... | text | 63 | integerItemType | text: <entity> 63 </entity> <entity type> integerItemType </entity type> <context> As of December 31, 2023, we held a 49 % interest in an unconsolidated real estate joint venture owning 63 facilities in the U.K. (the “Cindat Joint Venture”) accounted for using the equity method of accounting. As of December 31, 2023, o... | us-gaap:NumberOfRealEstateProperties |
As of December 31, 2023, we held a 49 % interest in an unconsolidated real estate joint venture owning 63 facilities in the U.K. (the “Cindat Joint Venture”) accounted for using the equity method of accounting. As of December 31, 2023, our equity interest was $ 97.6 million. The 63 facilities are subject to leases with... | text | 97.6 | monetaryItemType | text: <entity> 97.6 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023, we held a 49 % interest in an unconsolidated real estate joint venture owning 63 facilities in the U.K. (the “Cindat Joint Venture”) accounted for using the equity method of accounting. As of December 31, 2023... | us-gaap:EquityMethodInvestments |
In July 2024, we acquired the remaining 51 % interest in the Cindat Joint Venture for total consideration of $ 364.9 million inclusive of: (i) $ 98.9 million of cash consideration including direct transaction costs, (ii) the assumption of a £ 188.6 million mortgage loan (the “2026 Mortgage Loan”) with an estimated fair... | text | 98.9 | monetaryItemType | text: <entity> 98.9 </entity> <entity type> monetaryItemType </entity type> <context> In July 2024, we acquired the remaining 51 % interest in the Cindat Joint Venture for total consideration of $ 364.9 million inclusive of: (i) $ 98.9 million of cash consideration including direct transaction costs, (ii) the assumptio... | us-gaap:PaymentsToAcquireInterestInJointVenture |
In July 2024, we acquired the remaining 51 % interest in the Cindat Joint Venture for total consideration of $ 364.9 million inclusive of: (i) $ 98.9 million of cash consideration including direct transaction costs, (ii) the assumption of a £ 188.6 million mortgage loan (the “2026 Mortgage Loan”) with an estimated fair... | text | 264.0 | monetaryItemType | text: <entity> 264.0 </entity> <entity type> monetaryItemType </entity type> <context> In July 2024, we acquired the remaining 51 % interest in the Cindat Joint Venture for total consideration of $ 364.9 million inclusive of: (i) $ 98.9 million of cash consideration including direct transaction costs, (ii) the assumpti... | us-gaap:LoansAssumed1 |
In July 2024, we acquired the remaining 51 % interest in the Cindat Joint Venture for total consideration of $ 364.9 million inclusive of: (i) $ 98.9 million of cash consideration including direct transaction costs, (ii) the assumption of a £ 188.6 million mortgage loan (the “2026 Mortgage Loan”) with an estimated fair... | text | 2.0 | monetaryItemType | text: <entity> 2.0 </entity> <entity type> monetaryItemType </entity type> <context> In July 2024, we acquired the remaining 51 % interest in the Cindat Joint Venture for total consideration of $ 364.9 million inclusive of: (i) $ 98.9 million of cash consideration including direct transaction costs, (ii) the assumption... | us-gaap:AssetAcquisitionContingentConsiderationLiability |
During the second quarter of 2023, we purchased land located in Virginia (not reflected in the table above) for approximately $ 0.8 million that we plan to develop into a SNF. Concurrent with the acquisition, we amended our lease with an existing operator to include the land in the lease. We are committed to a maximum ... | text | 0.8 | monetaryItemType | text: <entity> 0.8 </entity> <entity type> monetaryItemType </entity type> <context> During the second quarter of 2023, we purchased land located in Virginia (not reflected in the table above) for approximately $ 0.8 million that we plan to develop into a SNF. Concurrent with the acquisition, we amended our lease with ... | us-gaap:PaymentsToAcquireCommercialRealEstate |
During the second quarter of 2023, we purchased land located in Virginia (not reflected in the table above) for approximately $ 0.8 million that we plan to develop into a SNF. Concurrent with the acquisition, we amended our lease with an existing operator to include the land in the lease. We are committed to a maximum ... | text | 15.2 | monetaryItemType | text: <entity> 15.2 </entity> <entity type> monetaryItemType </entity type> <context> During the second quarter of 2023, we purchased land located in Virginia (not reflected in the table above) for approximately $ 0.8 million that we plan to develop into a SNF. Concurrent with the acquisition, we amended our lease with... | us-gaap:OtherCommitment |
During the second quarter of 2023, we purchased land located in Virginia (not reflected in the table above) for approximately $ 0.8 million that we plan to develop into a SNF. Concurrent with the acquisition, we amended our lease with an existing operator to include the land in the lease. We are committed to a maximum ... | text | 2.5 | monetaryItemType | text: <entity> 2.5 </entity> <entity type> monetaryItemType </entity type> <context> During the second quarter of 2023, we purchased land located in Virginia (not reflected in the table above) for approximately $ 0.8 million that we plan to develop into a SNF. Concurrent with the acquisition, we amended our lease with ... | us-gaap:DevelopmentInProcess |
During the second quarter of 2023, we purchased land located in Virginia (not reflected in the table above) for approximately $ 0.8 million that we plan to develop into a SNF. Concurrent with the acquisition, we amended our lease with an existing operator to include the land in the lease. We are committed to a maximum ... | text | 2.4 | monetaryItemType | text: <entity> 2.4 </entity> <entity type> monetaryItemType </entity type> <context> During the second quarter of 2023, we purchased land located in Virginia (not reflected in the table above) for approximately $ 0.8 million that we plan to develop into a SNF. Concurrent with the acquisition, we amended our lease with ... | us-gaap:DevelopmentInProcess |
During the year ended December 31, 2024, we sold 21 facilities ( 14 SNFs, six ALFs and one specialty facility) for $ 95.0 million in net cash proceeds, recognizing a net gain of approximately $ 13.2 million. | text | 21 | integerItemType | text: <entity> 21 </entity> <entity type> integerItemType </entity type> <context> During the year ended December 31, 2024, we sold 21 facilities ( 14 SNFs, six ALFs and one specialty facility) for $ 95.0 million in net cash proceeds, recognizing a net gain of approximately $ 13.2 million. </context> | us-gaap:NumberOfRealEstateProperties |
During the year ended December 31, 2024, we sold 21 facilities ( 14 SNFs, six ALFs and one specialty facility) for $ 95.0 million in net cash proceeds, recognizing a net gain of approximately $ 13.2 million. | text | 14 | integerItemType | text: <entity> 14 </entity> <entity type> integerItemType </entity type> <context> During the year ended December 31, 2024, we sold 21 facilities ( 14 SNFs, six ALFs and one specialty facility) for $ 95.0 million in net cash proceeds, recognizing a net gain of approximately $ 13.2 million. </context> | us-gaap:NumberOfRealEstateProperties |
During the year ended December 31, 2024, we sold 21 facilities ( 14 SNFs, six ALFs and one specialty facility) for $ 95.0 million in net cash proceeds, recognizing a net gain of approximately $ 13.2 million. | text | six | integerItemType | text: <entity> six </entity> <entity type> integerItemType </entity type> <context> During the year ended December 31, 2024, we sold 21 facilities ( 14 SNFs, six ALFs and one specialty facility) for $ 95.0 million in net cash proceeds, recognizing a net gain of approximately $ 13.2 million. </context> | us-gaap:NumberOfRealEstateProperties |
During the year ended December 31, 2024, we sold 21 facilities ( 14 SNFs, six ALFs and one specialty facility) for $ 95.0 million in net cash proceeds, recognizing a net gain of approximately $ 13.2 million. | text | one | integerItemType | text: <entity> one </entity> <entity type> integerItemType </entity type> <context> During the year ended December 31, 2024, we sold 21 facilities ( 14 SNFs, six ALFs and one specialty facility) for $ 95.0 million in net cash proceeds, recognizing a net gain of approximately $ 13.2 million. </context> | us-gaap:NumberOfRealEstateProperties |
During the year ended December 31, 2024, we sold 21 facilities ( 14 SNFs, six ALFs and one specialty facility) for $ 95.0 million in net cash proceeds, recognizing a net gain of approximately $ 13.2 million. | text | 95.0 | monetaryItemType | text: <entity> 95.0 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2024, we sold 21 facilities ( 14 SNFs, six ALFs and one specialty facility) for $ 95.0 million in net cash proceeds, recognizing a net gain of approximately $ 13.2 million. </context> | us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment |
During the year ended December 31, 2024, we sold 21 facilities ( 14 SNFs, six ALFs and one specialty facility) for $ 95.0 million in net cash proceeds, recognizing a net gain of approximately $ 13.2 million. | text | 13.2 | monetaryItemType | text: <entity> 13.2 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2024, we sold 21 facilities ( 14 SNFs, six ALFs and one specialty facility) for $ 95.0 million in net cash proceeds, recognizing a net gain of approximately $ 13.2 million. </context> | us-gaap:GainLossOnDispositionOfAssets |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.